Pharmaceutical Industry Today

Women’s Health Therapeutics Market Growth, Share, Trends; Global Market Size to Reach USD 46.18 billion by 2030

Women’s Health Therapeutics Market to Register Major Growth due to Increasing Prevalence of Women-Specific Diseases and Increasing Healthcare Expenditure
Published 20 July 2023

The Women’s Health Therapeutics Market was valued at $13.8 billion in 2022, and it is projected to reach $46.18 billion by 2030, growing at a compound annual growth rate (CAGR) of 16.3% from 2023 to 2030, according to SNS Insider.

Women's health therapeutics refers to the branch of medicine and healthcare that focuses on diagnosing, treating, and managing health conditions and diseases that specifically affect women. It encompasses various medical specialties and addresses the unique biological, physiological, and psychosocial aspects of women's health.

Key Players Covered in Women’s Health Therapeutics market report are: Pfizer Inc, Novartis AG, Ferring B.V., Apothecus Pharmaceutical Corp, Agile Therapeutics, AstraZeneca, Merck & Co. Inc, Teva Pharmaceutical Industries Ltd, Lupin, Eli Lilly and other players

Get Report Sample @

Market Analysis

One of the key drivers of the women's health therapeutics market is the growing demand for effective treatments for reproductive health disorders. Conditions such as polycystic ovary syndrome (PCOS), endometriosis, infertility, and menstrual disorders affect a significant number of women worldwide. As understanding of these conditions improves and research progresses, novel therapies are being developed to target the underlying causes and provide more personalized treatment options.

Impact of Recession

A recession can have significant implications for the women's health therapeutics market. By addressing financial barriers, ensuring access to healthcare, supporting research and development, and prioritizing mental health, stakeholders can help mitigate the negative impact and ensure that women have equitable access to necessary therapeutics during challenging economic times.

Segmentation Analysis

The Pregnancy Segment and the Contraceptive Drugs Segment are set to dominate the women's health therapeutics market due to their significant impact on women's healthcare and the growing demand for specialized treatments. The Pregnancy Segment addresses the unique healthcare needs of pregnant women, while the Contraceptive Drugs Segment empowers women to exercise control over their reproductive choices.

Women’s Health Therapeutics Market Segmentation as Follows:

By Type:

·        Pregnancy

·        Oncology

o   Cervical Cancer

o   Ovarian Cancer

o   Uterine Cancer

o   Vaginal & Vulvar Cancer

·        Infection

By Application:

·        Contraceptive drugs

·        dysmenorrhea

·        Antibiotics

·        Antifungals

·        Hormone replacement

·        Acne treatment

·        bone health

Get Free Quarterly Updates, click on the link to enquire more @

Regional Status & Analysis

North America's dominance in the women's health therapeutics market can be attributed to a combination of factors, including a rising demand for specialized treatments, advancements in research and development, a supportive regulatory framework, and a robust healthcare infrastructure. By fostering collaboration, encouraging investment, and promoting knowledge sharing, the region continues to drive innovation in women's health therapeutics. These developments hold promise for improving healthcare outcomes and addressing the unique needs of women, leading to a brighter and healthier future.


The market is poised for significant growth and innovation in the coming years. Advancements in research, technology, and a greater focus on addressing gender-specific healthcare needs are driving the development of new and improved treatment options for a wide range of women's health conditions.

Frequently Asked Questions/ Key Reasons to Purchase this Report

What is the projected outlook for women’s health therapeutics market growth?

·        The market for women's health therapeutics is projected to exceed USD 46.18 billion by the year 2030.

What are the major factors influencing the women’s health therapeutics market?

·        With a comprehensive approach that encompasses reproductive health, cardiovascular health, oncology, mental health, and the integration of technology, the future of women's health therapeutics looks promising.

Who are the leading players in the women’s health therapeutics market?

·        Pfizer Inc, Teva Pharmaceutical Industries Ltd, Lupin, Apothecus Pharmaceutical Corp, Agile Therapeutics, Novartis AG, Ferring B.V., AstraZeneca, Merck & Co. Inc, Eli Lilly.

Table of Content

Chapter 1 Introduction

Chapter 2 Research Methodology

Chapter 3 Market Dynamics

Chapter 4. Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)

Chapter 5 Value Chain Analysis

Chapter 6 Porter’s 5 forces model

Chapter 7 PEST Analysis

Chapter 8 Women’s Health Therapeutics Market Segmentation, By Type

Chapter 9 Women’s Health Therapeutics Market Segmentation, By Application

Chapter 10 Regional Analysis

Chapter 11 Company profile

Chapter 12 Competitive Landscape

Chapter 13 Use Case and Best Practices

Chapter 14 Conclusion

Buy Women’s Health Therapeutics Market Report @

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)


Other Industry News

Ready to start publishing

Sign Up today!